Mueller Water Products Inc (NYSE:MWA)
Mueller Water Products, Inc. manufactures and markets products and services that are used in the transmission and distribution of safe, clean drinking water and in water treatment facilities. Their broad product portfolio includes engineered valves, fire hydrants, pipe fittings, water meters and ductile iron pipe, which are used by municipalities, as well as the residential and non-residential construction industries.
Mueller Water Products Inc (NYSE:MWA)’s Financial Overview
Mueller Water Products Inc (NYSE) surged 0.78% yesterday to close its trading session at $10.37. The company has 1 year Price Target of $12.95. Mueller Water Products Inc has 52-Week high of $12.59 and 52-Week Low of $8.47. The stock touched its 52-Week High on 12.59 and 52-Week Low on 8.47. The stock traded with the volume of 1.27 Million shares yesterday. The firm shows the market capitalization of $1.62 Billion.
Mueller Water Products Inc (NYSE) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $0.17/share against the analyst consensus estimate of $0.17/share. The difference between the actual and expected EPS is $0 a share with a surprise factor of 0%.
The firm is trading with SMA20 of 6.14 Percent, SMA50 of 7.19 Percent and SMA200 of -5.91 percent. Mueller Water Products Inc has P/S value of 1.74 while its P/B value stands at 3.04. Similarly, the company has Return on Assets of 2.4 percent, Return on Equity of 5.4 percent and Return on Investment of 8.9 Percent. The company shows Gross Margin and Operating Margin of 31.7 percent and 7.8 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 10 analysts offering 12-month price forecasts for Mueller Water Products Inc have a median target of 13.00, with a high estimate of 16.00 and a low estimate of 8.00. The median estimate represents a +25.36% increase from the last price of 10.37.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)
Infinity Pharmaceuticals, Inc. is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions.
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)’s Financial Outlook
The 2 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 2.75, with a high estimate of 3.00 and a low estimate of 2.50. The median estimate represents a +113.18% increase from the last price of 1.29.
Infinity Pharmaceuticals, Inc. is estimated to report earnings on 03/21/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 4 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.17. The reported EPS for the same quarter last year was $-0.14.
According to Zacks Investment Research, Infinity Pharmaceuticals, Inc. has a Consensus Recommendation of 3. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 1.57% and closed its last trading session at $1.29. The company has the market capitalization of $75.13 Million. The stock has 52-week high of $2.92 and 52-Week low of $1. The firm touched its 52-Week high on 2.92 and 52-Week low on 1.00. The company has volume of 156284 shares. The company has a total of 58.24 Million shares outstanding.
Infinity Pharmaceuticals, Inc. (NASDAQ) in the last quarter reported its actual EPS of $0.23/share where the analyst estimated EPS was $-0.15/share. The difference between the actual and Estimated EPS is $0.38. This shows a surprise factor of 253.3 percent.
The company has YTD performance of 9.32 percent. Beta for Infinity Pharmaceuticals, Inc. stands at 2.1 while its ATR (average true range) is 0.07. The company has Weekly Volatility of 5.10%% and Monthly Volatility of 5.15%%.
Infinity Pharmaceuticals, Inc. has distance from 20-day Simple Moving Average (SMA20) of 2.28%, Distance from 50-Day Simple Moving Average of 4.26 percent and Distance from 200-Day Simple Moving Average of -30.35%.
The Company currently has ROA (Return on Assets) of -18.2 percent, Return on Equity (ROE) of -20.8 Percent and Return on Investment (ROI) of 72.1% with Gross margin of 0 percent and Operating & Profit margin of -52.2% and -47% respectively.